🇺🇸 FDA
Patent

US 9937191

Inhibition of HIV infection through chemoprophylaxis

granted A61KA61K31/513A61K31/675

Quick answer

US patent 9937191 (Inhibition of HIV infection through chemoprophylaxis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/513, A61K31/675, A61K31/683, A61K31/7072